ANTIKÖRPER GEGEN A4 AMYLOIDPEPTID

Patent europeic · EP0440619 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP0440619
Numer da la dumonda
EP89903537
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
11-10-1988
Publitgà
14-08-1991
Concedì
24-01-1996
Stritgà
24-01-1996
Motiv
Nagin effect per la Svizra ed il Liechtenstein
Classas IPC
A61K 39/395 (2006.01)
C12N 5/00 (2006.01)
A61K 51/00 (2006.01)
A61K 49/00 (2006.01)
Prioritad
US 105751 08.10.1987
Dumonda PCT
PCT/US1988/003590 11.10.1988
Publicaziun PCT
WO1989/006242 13.07.1989
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 31-07-1996

    Midada

    Published in PIDTJ No 14 in 1996

  2. 28-06-1996

    Concedì

    Published in PIDTJ No 12 in 1996

Partidas

Possessur

The McLean Hospital Corporation

THE McLEAN HOSPITAL CORPORATION

115 Mill Street, Belmont, MA 02178, US

The University of Rochester

THE UNIVERSITY OF ROCHESTER

Office of Research and Project Administration, 30 Administration Building, Rochester, New York 14627, US

Inventur

MAJOCHA, Ron

Wayland, MA 01778, US

MAROTTA, Charles, A.

Cambridge, MA 02140, US

ZAIN, Sayeeda

Pittsford, NY 14534, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.